Fundz

Who to call at Olympus, and when

Fundz watches for the moments Olympus starts buying, and tells you who to reach.

  • An alert the day Olympus raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Olympus, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Olympus. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Olympus Enters Exclusive International Distribution Agreement with W. L. Gore & Associates for GORE® VIABIL® Biliary Endoprosthesis.

Oct 06, 2025

Contract Type

agreement

ShinjukuInformation TechnologyBiotechnologyHealth CareMedicalMedical Device

Description

Olympus has signed an international distribution agreement with W. L. Gore & Associates, granting Olympus exclusive rights to distribute the GORE® VIABIL® Biliary Endoprosthesis. This agreement enables Olympus to expand its offerings in the gastrointestinal metal stent market, starting commercialization in Europe and other regions in the coming months.

Quick answer

Olympus Enters Exclusive International Distribution Agreement with W. L. Gore & Associates for GORE® VIABIL® Biliary Endoprosthesis. (October 6, 2025). Olympus is based in Shinjuku, Tokyo, Japan.

What agreement did Olympus announce on October 6, 2025?
Olympus has signed an international distribution agreement with W. L. Gore & Associates, granting Olympus exclusive rights to distribute the GORE® VIABIL® Biliary Endoprosthesis. This agreement enables Olympus to expand its offerings in the gastrointestinal metal stent market, starting commercialization in Europe and other regions in the coming months.
What does Olympus do?
Olympus is passionate about creating customer-driven solutions for the medical industry.
Where is Olympus based?
Olympus is based in Shinjuku, Tokyo, Japan.

Source: Fundz verified event record.

Company Information

Company

Olympus

Location

Shinjuku, Tokyo, Japan

About

Olympus is passionate about creating customer-driven solutions for the medical industry. For more than 100 years, Olympus has focused on making people’s lives healthier, safer and more fulfilling by helping detect, prevent, and treat disease, furthering scientific research, and ensuring public safety.

Related People

Simone
Likely contact at this company
••••••••@••••••••

See Simone's verified email →

Soumyasanto
Senior decision-maker at this company
••••••••@••••••••

See Soumyasanto's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Olympus's next move

Learn about Strategic plan

Olympus signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.